A primer for developing pharmacist-managed clinics in the outpatient setting

Pharmacotherapy

Volumn 23, Issue 9 I, 2003, Pages 1153-1166

  Snella, Kathleen A ^a   Sachdev, Gloria P ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PHARMACY; CLINICAL PRACTICE; COOPERATION; COST; DOCUMENTATION; FINANCIAL MANAGEMENT; HEALTH SERVICES RESEARCH; HUMAN RELATION; INFORMATION PROCESSING; MANAGEMENT; MARKETING; MEDICAL STAFF; NURSING STAFF; OUTPATIENT; PHARMACIST; PLANNING; REVIEW; SUPPORT GROUP;

AMBULATORY CARE FACILITIES; HUMANS; INTERPROFESSIONAL RELATIONS; PHARMACEUTICAL SERVICES; PHARMACISTS; PHARMACY ADMINISTRATION; PRACTICE GUIDELINES; PROFESSIONAL PRACTICE; PROGRAM DEVELOPMENT;

EID: 0141456720     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.23.10.1153.32758     Document Type: Review

References (51)

1. Morrison A, Wertheimer AI. Evaluation of studies investigating the effectiveness of pharmacist's clinical services. Am J Health-Syst Pharm 2001;58:569-77.
2. American College of Clinical Pharmacy. A vision of pharmacy's future roles, responsibilities, and manpower needs in the United States. Pharmacotherapy 2000;20(8):991-1020.
3. American College of Clinical Pharmacy. A vision of pharmacy's future roles, responsibilities, and manpower needs in the United States [correction]. Pharmacotherapy 2000;220(9):1145-6.
4. Helling DK, Nelson KM. How to develop and implement a program to continuously demonstrate the value of clinical pharmacy services. Pharmacotherapy 2000;20(10 pt 2):340S-3.
5. Hart AC, Schmidt K, eds. ICD-9-CM. Expert for physicians, volumes 1 and 2, 6th ed. Salt Lake City, UT: Ingenix, 2003.
6. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2003;26:33-50.
7. The National Cholesterol Education Program. Third report of the expert panel on detection, evaluation, and treatment of the high blood cholesterol in adults (adult treatment panel III): final report. Bethesda, MD: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung and Blood Institute, 2002.
8. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289(19):2560-71.
9. Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KMV. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med 2002;136:565-74.
10. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
11. National Committee for Quality Assurance. NCQA overview. Available from www.ncqa.org/Communications/Publications/overviewncqa.pdf. Accessed November 12, 2002.
12. National Committee for Quality Assurance. HEDIS® 2002 summary table of measures, product lines, and changes. Available from www.ncqa.org/Programs/HEDIS/O2measures. pdf. Accessed November 12, 2002.
13. Texas Diabetes Council. Minimum standards for diabetes care in Texas. Available from www.tdh.state.tx.us/diabetes/min.htm. Accessed November 12, 2002.
14. To LL, Stoner CP, Stolley SN, Buenviaje JD, Ziegler TW. Effectiveness of a pharmacist-implemented anemia management protocol in an outpatient hemodialysis unit. Am J Health-Syst Pharm 2001;58:2061-65.
15. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care. Arch Intern Med 1998;158:1641-7.
16. Norton JL, Gibson DL. Establishing an outpatient anticoagulation clinic in a community hospital. Am J Health-Syst Pharm 1996;53:1151-7.
17. Moherman LJ, Kolar MM. Complication rates for a telephone-based anticoagulation service. Am J Health-Syst Pharm 1999;56:1540-2.
18. Garabedian-Ruffalo SM, Gray DR, Sax MJ, Ruffalo RL. Retrospective evaluation of a pharmacist-managed warfarin anticoagulation clinic. Am J Hosp Pharm 1985;42:304-8.
19. Pauley TR, Magee MJ, Curry JD. Pharmacist-managed, physician-directed asthma management program reduces emergency department visits. Ann Pharmacother 1995;29:5-9.
20. Sterné SC, Gundersen BP, Shrivastava D. Development and evaluation of a pharmacist-managed asthma education clinic. Hosp Pharm 1999;34:699-706.
21. Rupp MT, McCallian DJ, Sheth KK. Developing and marketing a community pharmacy-based asthma management program. J Am Pharm Assoc 1997;NS37:694-9.
22. Irons BK, Lenz RJ, Anderson SL, Wharton BL, Habeger B, Anderson HG. A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic. Pharmacotherapy 2002;22(10):1294-300.
23. Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother 1996;30(3):238-43.
24. Coast-Senior EA, Kroner BA, Kelley CL, Trilli LE. Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother 1998;32(6):636-41.
25. Davidson MB, Karlan VJ, Hair TL. Effect of a pharmacist-managed diabetes care program in a free medical clinic. Am J Med Qual 2000;15(4):137-42.
26. Segarra-Newnham M, Siebert WF. Development and outcomes of an ambulatory clinic for Helicobacter pylori treatment. Hosp Pharm 1998;33:205-9.
27. Patchin GM, Wieland KA, Carmichael JM. Six months' experience with a pharmacist-run Helicobacter pylori treatment clinic. Am J Health-Syst Pharm 1996;53:2081-2.
28. Morreale, AP. Pharmacist-managed Helicobacter pylori clinic. Am J Health-Syst Pharm 1995;52:183-5.
29. Okamoto MP, Nakahiro RK. Pharmacoeconomic evaluation of a pharmacist managed hypertension clinic. Pharmacotherapy 2001;21(11):1337-44.
30. Mehos BM, Sasseen JJ, MacLaughlin EJ. Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension. Pharmacotherapy 2000;20(11):1384-9.
31. Bozovich M, Rubino CM, Edmunds J. Effect of a clinical pharmacist managed lipid clinic on achieving national cholesterol education program low, density lipoprotein goals. Pharmacotherapy 2000;20(11):1375-83.
32. O'Donnell DC, Chen NT, Piziak VK. Goal attainment and maintenance of serum cholesterol level in a pharmacist coordinated lipid clinic. Am J Health-Syst Pharm 2001;58:325-30.
33. Van Amburgh JA, Waite NM, Hobson EH, Migden H. Improved influenza vaccination rates in a rural population as a result of a pharmacist-managed immunization campaign. Pharmacotherapy 2001;21(9):1115-22.
34. D'Achille KM, Swanson LN, Hill WT. Pharmacist-managed patient assessment and medication refill clinic. Am J Hosp Pharm 1978;35:66-70.
35. Cassidy IB, Keith MR, Coffey EL, Noyes MA. Impact of pharmacist-operated general medicine chronic care refill clinics on practitioner time and quality of care. Ann Pharmacother 1996;30:745-51.
36. Cram DL, Maesner AT, Witmore DM. Medication refill clinics: the Veterans Administration Medical Center experience. J Pharm Pract 1992;5(1):12-21.
37. McNicholl IR, Raebel MA. Malaria epidemiology and economics in a pharmacist-managed international travel clinic. Pharmacotherapy 1999;19(12):1363-8.
38. Borgsdorf LR, Miano JS, Knapp KK. Pharmacist-managed medication review in a managed care setting. Am J Hosp Pharm 1994;51:722-7.
39. Yanchick, JK. Implementation of a drug therapy monitoring clinic in a primary care setting. Am J Health-Syst Pharm 2000;57(suppl 4):S30-7.
40. Jermain DM, Sulak PJ, Woodward BW, Knight AB. Psychopharmacy medication clinic in a managed care women's health setting. Am J Health-Syst Pharm 1997;54:2717-18.
41. Konzem SL, Morreale AP, Kaplan LA. Pharmacist-managed primary care dermatology clinic. Hosp Pharm 1996;31:823-5, 834.
42. Jameson J, VanNoord G, Vanderwoud K. The impact of a pharmacotherapy consultation on the cost and outcome of medical therapy. J Fam Pract 1995;41:469-72.
43. Carmichael JM, O'Connell MB, Devine B, et al. Collaborative drug therapy management by pharmacists. Pharmacotherapy 1997;17(5):1050-61.
44. Boatwright D. Legal aspects of expanded prescribing authority for pharmacists. Am J Health-Syst Pharm 1998;55:585-94.
45. Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL. Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy 2003;23(1):113-32.
46. Hogue MD. The pharmacist's guide to compensation for patient care services. Washington, DC: American Pharmaceutical Association, 2002:ix.
47. Department of Health and Human Services. Medicare carriers manual, part 3: claims process. Transmittal 1764. August 28, 2002. Available from www.cms.hhs.gov/manuals/pm_trans/R1764B3.pdf. Accessed November 12, 2002.
48. Snella KA. Specific billing scenarios. In: American Association of Clinical Pharmacy: how to bill for clinical pharmacy services. Kansas City, MO: American College of Clinical Pharmacy, 1999.
49. Centers for Medicare and Medicaid Services. Hospital outpatient prospective payment system. Available from http://cms.hhs.gov/regulations/hopps/. Accessed January 27, 2003.
50. Centers for Medicare and Medicaid Services. Medicare program: changes to the hospital outpatient prospective payment system and calendar year 2003 payment rates, and changes to payment suspension for unfilled cost reports. Federal Register 2002;67(212):66718-67046. Also available from http://www.cms.hhs.gov/providerupdate/regs/cms1206fcl.pdf and http://www.cms.hhs.gov/providerupdate/regs/cms1206fc3.pdf, Accessed January 28, 2003.
51. American College of Clinical Pharmacy. Establishing and evaluating clinical pharmacy services in primary care. Pharmacotherapy 1994;14:743-58.